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ABSTRACT
Background: HIV testing is crucial in identifying and initiating the treatment of 
HIV/AIDS. In recent years, the Oral Rapid Tests (ORT) has become one of the 
most popular tests based on saliva. This paper aims to present the response from 
research subjects who took the ORT using OraQuick®. 
Discussion: A total of 2657 studies was obtained. Finally, 21 articles matched 
to our review. The 21 included studies showed the advantages of ORT such as 
comfortable 91%, easy to use 76%, quick results 54%, preferred choice 67%, 
maintains confidentiality 54% and other reasons. Our reviewed studies demonstrated 
the consistent high acceptability of the oral rapid test in HIV.
Conclusion: The comforts stem from ORT with OraQuick® are being contributed 
by its easy to use characteristic and non-blood-withdrawn comfortable method
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INTRODUCTION
In 2017, globally people living with HIV 
reached 36.9 million.1 Strategies to combat 
HIV/AIDS are based on early detection of HIV 
infection and appropriate treatment planning. 
In general conventional strategy for HIV testing 
is the use of the specific antibody screening 
such as the ELISA test.1,2,3 This cannot always 
be done in a developing country because it re-
quires expensive customized laboratory equip-
ment with expert staffs.2,4 Also those who are 
at high risk of HIV infection are sometimes 
constrained in the process of blood-taking due 
to perceived pain from the injection.5
In 2004, a rapid HIV-antibody-based test 
named OraQuick® advance rapid HIV-1/2 
(OraSure Technologies Inc, PA, USA) was 
approved by the US Food and Drug Admin-
istration (FDA) to use with specimens of oral 
mucosal transudate.6 In recent years, ORT has 
become one of the most popular saliva-based 
tests. It is more acceptable to most patients be-
cause of the non-invasive specimen collection, 
quick result, and ease of use.7,8 Some even 
promoted the OraQuick® for a home self-test-
ing of HIV.6,9
Unfortunately in Indonesia, ORT is highly 
unpopular and in general is a strange con-
cept for medical and dental practitioners even 
though the ORT is more appealing to invite 
people to screen for early HIV infection. Espe-
cially in areas that are difficult to reach and lab-
oratory facilities are not available. This study 
aims to present the advantages of ORT using 
OraQuick® to serve as a supporting literature 
in the use of OraQuick® for the dental practi-
tioner.
LITERATURE REVIEW
The literature was conducted according to 
the Preferred Reporting Items For Systematic 
Reviews and Meta-Analyses Protocols (PRIS-
MA-P) 2015 statement.10
Based on the PRISMA guidelines, 1 fo-
cused PICO (population, intervention, compar-
ison, and outcome) question were constructed: 
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1) What are the advantages of ORT compared 
to blood tests?
Pubmed, Science Direct, the Cochrane Li-
brary and the Global Health Database were 
systematically searched for matching manu-
scripts and a comprehensive Google search 
was performed for gray literature. Search 
terms included ‘Oral Rapid Test’ AND ‘HIV’ OR 
‘Self-test’ OR ‘Home-test’. We conducted the 
search without date restriction from 2010 until 
August 1st, 2018 in English language referenc-
es available. 
Inclusion criteria. Full-text articles were in-
cluded regardless of the time period of study 
and year of publication.
The studies included had to be an original 
article published in scientific journals, ran-
domized control trial, cross-sectional or cohort 
studies, comparative studies, only humans 
and written in the English language.Individuals 
with HIV infection or not. No restriction for HIV 
diagnosis classification criteria was applied.
We expect this ORT to become a new 
breakthrough as technology develops as an 
HIV fast test that is accurate and in great de-
mand by the public. 
Exclusions criteria. The quality of journals 
that are not included in the Scopus index and 
the case report studies. Literature presented 
outside of English was also excluded from this 
study.
The quality of the reference from this study 
uses Scopus with results consisting of Q1 in 15 
studies, Q2 in 4 studies, and Q3 in 2 studies. 
Follow the procedures according to Joanna 
Briggs Institue (JBI) to see the bias from the 
reviewed literature.11
In determining the results of this study, we 
categorize groups based on their respective 
types of research. The outcome of the pre-
ferred Oral Rapid Test HIV from the included 
studies was presented as a percentage dis-
played in the form of tables (Table 3).
The search strategy resulted in 2657 arti-
cles, which then filtered to finally got 21 publi-
cations that were eligible for our review (Figure 
1). We reviewed the quality of these 21 studies, 
15 studies were in quartile 1 (Q1), 4 research 
on Q2, and 2 research on Q3 (Table 1).
There are 14 cross-sectional and 5 research 
Figure 1. Flow diagram of the literature search, according to the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA).
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studies with descriptive cross-sectional, 1 ar-
ticles with cohort studies, and 1 articles with 
randomized controlled trials. All research is 
published between 2010 and 2018 (Table 1,2).
Participants liked and chose Oral Rapid Test 
to screen early on HIV detection mainly due to 
its practical and painless reasons. The 21 in-
cluded studies showed the advantages of ORT 
such as comfortable 91%, easy to use 76% , 
quick results 54%, preferred choice 67%, main-
tains confidentiality 54% and the others reason 
like a self-testing at home, enable frequent 
Tabel 1. Studies included in the review    
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testing, should sold in public, recommended to 
use for community, importance, willingness to 
pay and benefited (Table 3).
The use of this device is only in developing 
countries. The absence of calibration of this tool 
by default and according to evidence-based 
medicine.
There is a possibility of literature in oth-
er languages than English that discusses the 
same topic as this paper. This paper also col-
lects data from various developing countries 
with high risk prevalence and does not cover 
all countries including Indonesia.
DISCUSSION
ORT is the latest technological break-
through that has been internationally recog-
nized and has been approved by the USA 
FDA.33 Where the accuracy has been tested 
and carried out by various developing coun-
tries with the results of sensitivity and specific-
ity that are almost equal to conventional tests 
such as ELISA.6,34
Some of this research was carried out on 
populations at high risk of HIV and also preg-
nant women because it is very high risk to 
transmit infection to surrounding communities, 
Tabel 2. The population and type of research studies
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Tabel 3. Results of selected studies according to the outcome review
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especially in pregnant women who will trans-
mit to the babies they conceive as the results 
of research conducted by Pant Pai et al in In-
dia, where the author stated the importance of 
screening HIV tests on pregnant women as the 
last chance to prevention of mother-to-child 
HIV transmission (PMTCT), especially in set-
tings where women do not receive adequate 
antenatal care.35
Of all the studies both analytic and descrip-
tive studies that have been conducted in sev-
eral countries, participants generally prefer 
HIV screening with oral rapid test compared to 
conventional tests.12,13,18 The main reason for 
the participants is due to the absence of pain 
from the blood-taking activity.14,15 Conventional 
HIV testing is done by taking blood samples 
which will be seen are HIV antibodies that can 
also be found in saliva. This is very helpful es-
pecially for people who are afraid of needles 
and do not want to be hurt by taking blood. 
Similar with results of the studies by Zachary 
et al which experience, oral fluid-based test-
ing offers many advantages over blood-based 
testing, especially with self-testing on the hori-
zon.36
The result is faster just waiting for about 
20 minutes which we can see in the research 
results in the table above.27,37,38 This tool is 
known as lateral flow immunoassays, which 
essentially coax analytes (HIV antibodies, in 
this case) up from cotton or the tip and into 
the yield area. Once they’re in that area, two 
wall-like strips called membranes capture the 
analyte and show up as colored lines.6,38 This 
HIV antibody test detects cells created by the 
immune system (defense) in response to HIV 
infection. Most HIV tests detect the presence 
of HIV antibodies, not the HIV virus.6,37
This tool just enough to swabbing it be-
tween the gums and teeth.6,37 The potential 
benefits of HIV self-testing include increased 
access to testing and early diagnosis for peo-
ple living with HIV.39,40 People who do self-tests 
also experience greater comfort, autonomy, 
and privacy when testing, and this is possible 
provides options for individuals who do not 
use existing HTC services or those who do not 
have regular contact with (or access to) health 
services where HIV testing is offered.37,39 This 
ORT can be used privately at home so it is 
more appropriate for use by populations with 
high HIV prevalence. Thus, it is easier to ac-
cess especially health workers in minimizing 
the impact of the increasing incidence of HIV 
infection in a region.
So far there are no risks associated with the 
use of ORT, there are no adverse events or 
hazards has been reported to date (for exam-
ple there are no human rights violations from 
HIV self-testing abuse, or no reports of vio-
lence or self-harm.37 
The oral fluid HIV test is very accurate. This 
test is FDA-approved with> 99% sensitivity 
and specificity claimed in many types of spec-
imens, including oral fluids. In several studies, 
the OraQuick® In-Home HIV Test detected 
more than 91.7 percent of people infected with 
HIV, and 99.9 percent of people who were not 
infected with HIV.6,37,41,42
In 2016, approximately 102 million HIV 
RDTs for professional use were reportedly pro-
cedure by the Global Fund, PEPFAR, UNICEF, 
and WHO. On June 27, 2017, the Charity Sup-
port Agreement between Bill&Melinda Gates
The Foundation an OraSure Technol-
ogies Inc. were announced to reduce Ora-
Quick® costs HIV Self-Test for public sector 
buyers  in  50  low-income  /  heavy-burden 
countries.  Funding  to  activate  a  more afford-
able  price  ($  2.00  ex-works)  will  consist  of 
related  support  payments  volume  of prod-
ucts sold and reimbursement of certain related 
costs.37
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This test will also detect samples with pre-
dominantly IgM reactivity. The report of studies 
by Guillon et al detect IgM antibodies during an 
acute infection window period of approximately 
20-25 days after infection.6
CONCLUSIONS
We concluded that high acceptance of Oral 
Rapid Test HIV, which in addition to easy, quick 
results and comfortable, also has high accura-
cy to match other conventional tests. Countries 
should make Oral Rapid Test as the HIVST 
available and determine over the counter for 
strategies to facilitate linkage, cost- effective-
ness, and the pathway to create supportive 
policies will be needed to maximize the poten-
tial of introducing HIVST.
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